| PET-CT surveillance versus neck dissection in advanced head and neck cancer H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ... New England Journal of Medicine 374 (15), 1444-1454, 2016 | 641 | 2016 |
| PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned … H Mehanna, CC McConkey, JK Rahman, WL Wong, AF Smith, C Nutting, ... National Institute for Health Research, 2017 | 88 | 2017 |
| Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data. PS Hall, P Hamilton, C Hulme, D Meads, J H, N A, M J, S AF, M H, V G, ... British Journal of Cancer, 2015 | 81 | 2015 |
| Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial PS Hall, A Smith, C Hulme, A Vargas-Palacios, A Makris, ... Value in Health 20 (10), 1311-1318, 2017 | 50 | 2017 |
| The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation PS Hall, ED Mitchell, AF Smith, DA Cairns, M Messenger, M Hutchinson, ... Health Technology Assessment (NIHR), 2018 | 48 | 2018 |
| Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer AF Smith, PS Hall, CT Hulme, JA Dunn, CC McConkey, JK Rahman, ... European Journal of Cancer 85, 6-14, 2017 | 35 | 2017 |
| Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL DR Howard, T Munir, L McParland, AC Rawstron, D Milligan, A Schuh, ... Leukemia 31 (11), 2416-2425, 2017 | 34 | 2017 |
| Early economic evaluation of diagnostic technologies: experiences of the NIHR Diagnostic Evidence Co-operatives L Abel, B Shinkins, A Smith, A Sutton, G Sagoo, U I, J Allen, S Graziadio, ... Medical Decision Making, 2019 | 33 | 2019 |
| Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on … A Smith, B Shinkins, P Hall, C Hulme, M Messenger Clinical Chemistry, 2019 | 32 | 2019 |
| The delivery of chemotherapy at home: an evidence synthesis M Corbett, M Heirs, M Rose, A Smith, L Stirk, G Richardson, D Swinson, ... Health Service and Delivery Research 3 (14), 2015 | 21 | 2015 |
| Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare … DR Howard, T Munir, L McParland, AC Rawstron, A Chalmers, ... Health Technology Assessment (Winchester, England) 21 (28), 1-374, 2017 | 15 | 2017 |
| Setting analytical performance specifications using HbA1c as a model measurand TP Loh, AF Smith, KJL Bell, SJ Lord, F Ceriotti, G Jones, P Bossuyt, ... Clinica Chimica Acta 523, 407-414, 2021 | 13 | 2021 |
| The role of measurement uncertainty in health technology assessments (HTAs) of in vitro tests AF Smith, M Messenger, P Hall, C Hulme PharmacoEconomics 36, 823-835, 2018 | 8 | 2018 |
| Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy? O Ragy, V Rautemaa, A Smith, P Brenchley, D Kanigicherla, P Hamilton PLoS One 18 (2), e0281726, 2023 | 6 | 2023 |
| The clinical and cost effectiveness of ustekinumab for the treatment of psoriatic arthritis: a critique of the evidence J O’Connor, S Rice, A Smith, M Rodgers, RR Lopez, D Craig, N Woolacott PharmacoEconomics 34, 337-348, 2016 | 5 | 2016 |
| Early cost-effectiveness analysis of new medical tests: Response AF Smith, A Sutton, B Shinkins International journal of technology assessment in health care 32 (4), 324-325, 2016 | 5 | 2016 |
| Integrating early economic evaluation into target product profile development for medical tests: advantages and potential applications P Cocco, MP Messenger, AF Smith, RM West, B Shinkins International Journal of Technology Assessment in Health Care 37 (1), e68, 2021 | 4 | 2021 |
| An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation model AF Smith, SN Frempong, N Sharma, RD Neal, L Hick, B Shinkins BMC Health Services Research 22 (1), 1301, 2022 | 3 | 2022 |
| Methods to assess the impact of test measurement uncertainty on downstream clinical outcomes: A case study of faecal calprotectin (FC) for the diagnosis of Inflammatory Bowel … A Smith, B Shinkins, C Hulme, P Hall, M Messenger Clinica Chimica Acta 493, S353-S354, 2019 | 1 | 2019 |
| Beyond the laboratory: A review of indirect methods to assess the impact of test measurement uncertainty on downstream clinical and cost outcomes A Smith, B Shinkins, C Hulme, P Hall, M Michael Clinica Chimica Acta 493, S353, 2019 | 1 | 2019 |
Peter S HallUniversity of Edinburgh在 ed.ac.uk 的电子邮件经过验证
